Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-18

Clinical Trial Update: Viscoat Versus Visthesia. A Comparative Study of Post-cataract Endothelial Cell Loss [NA]

View source ↗

Summary

Completed clinical trial comparing Viscoat and Visthesia for cataract surgery, assessing postoperative endothelial cell loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viscoat (sodium chondroitin sulfate + sodium hyaluronate)
  • Visthesia (sodium hyaluronate)

Snippet

Sponsor: Democritus University of Thrace | Conditions: Cataract | NA | Status: COMPLETED